CLINICAL_TRIALS
trial_result
· 2023-03-22
Clinical Trial Update: Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery [Phase 2]
Summary
Phase 2 trial update for andexanet in patients on an oral Factor Xa inhibitor needing urgent surgery; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Surgery | Phase 2 | Status: TERMINATED | Results posted: 2023-03-22